NCT03920735 is a clinical trial in Hematologic Disease, sponsored by University Hospital, Strasbourg, France.

Who is sponsoring NCT03920735?

NCT03920735 is sponsored by University Hospital, Strasbourg, France.

What condition does NCT03920735 study?

NCT03920735 studies Hematologic Disease, Neoplams, Transplantation, Immunologic Deficiency Syndromes, Critical Illness.

Is NCT03920735 still recruiting?

NCT03920735 is currently status unknown. Last updated 19 April 2019.

Last reviewed 2019-04-19 · How we verify

NCT03920735

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail Patients

Status unknown Last updated 19 April 2019

What this trial tests

trial in Hematologic Disease in 1,000 participants. Status unknown.

Timeline

15 March 2017

Primary endpoint
15 July 2019

15 July 2019

Quick facts

Lead sponsor	University Hospital, Strasbourg, France
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	15 March 2017
Primary completion	15 July 2019
Estimated completion	15 July 2019
Sites	1 location across France

Conditions studied

Hematologic Disease — all drugs for Hematologic Disease →
Neoplams — all drugs for Neoplams →
Transplantation — all drugs for Transplantation →
Immunologic Deficiency Syndromes — all drugs for Immunologic Deficiency Syndromes →

Sponsor

University Hospital, Strasbourg, France

Who can join

Eligibility, any sex, with Hematologic Disease or Neoplams. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The analysis of a cohort of consecutive non-selected patients from the Strasbourg University Hospital, and therefore representative of the real life, will allow better identifying the risk factors for these infections (by comparison with a cohort of patient with similar conditions of immunosuppression and no infection) and improving the diagnosis and therapeutic management. The primary objective is to identify prognosis factors affecting survival in patients with opportunistic infections

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Fungal Infections Caused by Kazachstania spp., Strasbourg, France, 2007-2020.
Kaeuffer C, Baldacini M, Ruge T, Ruch Y, et al · · 2022 · cited 14× · PMID 34932452 · DOI 10.3201/eid2801.211543
<i>Fusarium</i>, <i>Scedosporium</i> and Other Rare Mold Invasive Infections: Over Twenty-Five-Year Experience of a European Tertiary-Care Center.
Ledoux MP, Dicop E, Sabou M, Letscher-Bru V, et al · · 2024 · cited 3× · PMID 38667960 · DOI 10.3390/jof10040289

Verify or expand the search:

Other recruiting trials for Hematologic Disease

Currently open trials in the same condition.

NCT06849921 — Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors · NA · active not recruiting
NCT06809712 — Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation · Phase 1 · recruiting

Other University Hospital, Strasbourg, France trials

Trials by the same sponsor.

NCT07418554 — Sleep Disturbances in Children and Adolescents With Post-traumatic Stress Disorder (PTSD): a Randomized Double-blind Pla · Phase 3 · not yet recruiting
NCT07108582 — Reducing Chronic Pain After Lung Surgery: A Trial of Limiting NSAIDs During Recovery · Phase 3 · not yet recruiting
NCT07302646 — Optimizing Reduced-Flow, Low-Volume Contrast Protocols for Cerebral Angiography in Unruptured Aneurysms · NA · not yet recruiting
NCT07273968 — Clinical Study Evaluating the Effect of Virtual Reality on Reducing Patients' Anxiety During Wisdom Teeth Extraction · NA · not yet recruiting
NCT07214103 — Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulop · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03920735 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Strasbourg, France
Last refreshed: 19 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03920735.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing